In studies focused on cell proliferation inhibition, hyperoside was shown to inhibit the activity of the Akt/mTOR/p70S6K signaling pathway in a dose-dependent manner, promoting autophagy and thereby exerting anti-tumor effects (Fu et al., 2016). The gene discussed is AKT1; the disease is neoplasm.